Latest Articles

Publication Date
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer - CancerNetwork

FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer CancerNetwork

Published: Nov. 12, 2025, 7:12 p.m.
FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma - Targeted Oncology

FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma Targeted Oncology

Published: Nov. 12, 2025, 7:08 p.m.
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer - University of Miami

Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer University of Miami

Published: Nov. 12, 2025, 1:59 p.m.
The efficacy of adjuvant therapies in improving endometrial function of women undergoing assisted reproductive technology: a systematic review and network meta-analysis - BMC Pregnancy and Childbirth

The efficacy of adjuvant therapies in improving endometrial function of women undergoing assisted reproductive technology: a systematic review and network meta-analysis BMC Pregnancy and Childbirth

Published: Nov. 12, 2025, 1:46 p.m.
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - BioSpace

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma BioSpace

Published: Nov. 12, 2025, 4:01 a.m.
Mathematical model of optimal control for endometrial cancer with treatments dostarlimab and chemotherapy using Caputo derivative - Nature

Mathematical model of optimal control for endometrial cancer with treatments dostarlimab and chemotherapy using Caputo derivative Nature

Published: Nov. 11, 2025, 8:42 p.m.
Development of a senescence-related lncRNA signature in endometrial cancer based on multiple machine learning models - Frontiers

Development of a senescence-related lncRNA signature in endometrial cancer based on multiple machine learning models Frontiers

Published: Nov. 11, 2025, 4:15 p.m.
High-Intensity Focused Ultrasound (HIFU) as a Combined Approach for the Treatment of Recurrent Low-Grade Endometrial Stromal Sarcoma: A Case Report and Literature Review - Frontiers

High-Intensity Focused Ultrasound (HIFU) as a Combined Approach for the Treatment of Recurrent Low-Grade Endometrial Stromal Sarcoma: A Case Report and Literature Review Frontiers

Published: Nov. 10, 2025, 4:21 p.m.
Adverse Event and Quality-of-Life Considerations in Endometrial Cancer - OncLive

Adverse Event and Quality-of-Life Considerations in Endometrial Cancer OncLive

Published: Nov. 10, 2025, 1:37 p.m.
Bar Levy: Endometrial Cancer Must Be Prioritized in Global Health Policy - Oncodaily

Bar Levy: Endometrial Cancer Must Be Prioritized in Global Health Policy Oncodaily

Published: Nov. 10, 2025, 11:06 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!